CPH Group Reports Earnings and Strategic Outlook for FY2025

The CPH Group has reported its FY2025 financial results, striking a tone of cautious optimism amid strategic expansion. Net sales increased by 3.3% year-on-year to CHF 334.1 million, mainly driven by acquisitions. However, the group faced challenges from currency effects and organic factors, leading to a decline in EBITDA by 6.5% to CHF 50.3 million with a margin drop to 15.0%.

EBIT stood at CHF 32.8 million, while net income fell to CHF 23.4 million, impacted by the lack of one-time income from the prior year and increased financial expenses. Cash flow from operations decreased significantly, highlighting the pressure on liquidity amid rising working capital.

In a segmented performance, Zeochem's sales decreased but achieved record EBITDA, while Perlen Packaging saw sales growth hindered by external pressures. For FY2026, CPH anticipates returning to profitable growth, focusing on acquisition integration and leveraging market trends in health and energy.